04/03/2024
4:00 PM | Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:13 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:32 AM | Verve Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
7:00 AM | Verve Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:45 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
|
01/23/2024
9:13 AM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
01/16/2024
10:45 AM | SINGER JAMES R (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/11/2023
8:09 AM | FMR LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
12/05/2023
3:50 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Verve Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2023
3:30 PM | Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:30 PM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
3:54 PM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
3:47 PM | Verve Therapeutics (Filer)
| Form 424B5 | |
11/28/2023
3:25 PM | Verve Therapeutics (Filer)
| Form 424B5 | |
11/13/2023
5:34 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:00 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
5:41 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:00 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
8:02 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
5:37 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:33 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
6:00 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
6:49 AM | Verve Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023
6:52 AM | Verve Therapeutics (Filer)
| Form ARS | |
04/28/2023
6:30 AM | Verve Therapeutics (Filer)
| Form DEF 14A | |
